Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells

Dades bibliogràfiques
Autors principals:	Dan Nakano, Takumi Kawaguchi, Tsubasa Tsutsumi, Masako Hayakawa, Sachiyo Yoshio, Hironori Koga, Takuji Torimura
Format:	Article
Idioma:	English
Publicat:	Wiley 2022-04-01
Col·lecció:	JGH Open
Matèries:	chemokine cytokine hepatoma sodium‐glucose cotransporter 2 tumor microenvironment
Accés en línia:	https://doi.org/10.1002/jgh3.12730

Ítems similars

Gene cloning and expression analysis of Gro/KC by primary hepatocytes
per: GH. Hassanshahi, et al.
Publicat: (2007-01-01)

Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells
per: Elodie Jouan, et al.
Publicat: (2016-12-01)

Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
per: Toru Nakamura, et al.
Publicat: (2024-10-01)

Chemokines, chemokine receptors and disease : current topics in membranes /
per: Schwiebert, Lisa M.
Publicat: (2005)

Suppression Effect of Eurycomanone on the Growth of Human Hepatoma Cells (Hepg2) by Inducing P53-Mediated Apoptotic Pathway
per: Zakaria, Yusmazura
Publicat: (2009)

Düzeltme: Gossypinin insan hepatom (Hep-3B) hücreleri üzerindeki antiproliferatif etkisi
per: İrfan Çınar
Publicat: (2021-03-01)

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
per: Valeria Mollica Poeta, et al.
Publicat: (2019-03-01)

Chemokines and chemokine receptors expression in the lesions of patients with American cutaneous leishmaniasis
per: Nilka Luisa Diaz, et al.
Publicat: (2013-06-01)

The role of chemokines and chemokine receptors in eosinophil activation during inflammatory allergic reactions
per: Oliveira S.H.P., et al.
Publicat: (2003-01-01)

Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
per: Elemam NM, et al.
Publicat: (2020-03-01)

Seric chemokines and chemokine receptors in eosinophils during acute human schistosomiasis mansoni
per: Denise Silveira-Lemos, et al.
Publicat: (2010-07-01)

Chemokines and chemokine receptors in Behçet’s disease
per: Zhan Li, et al.
Publicat: (2023-01-01)

Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain
per: Martina Vincenzi, et al.
Publicat: (2022-03-01)

Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
per: Masanori A. Murayama, et al.
Publicat: (2023-02-01)

The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma
per: Wu Z, et al.
Publicat: (2024-05-01)

Chemokines and chemokine receptors: A new strategy for breast cancer therapy
per: Hui Liu, et al.
Publicat: (2020-06-01)

Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway
per: Wenyue Zhang, et al.
Publicat: (2020-07-01)

EXPRESSION OF mRNAS FOR CHEMOKINES AND CHEMOKINE RECEPTORS IN THE SKIN FROM PATIENTS WITH PSORIASIS
per: A. S. Beltiukova, et al.
Publicat: (2014-07-01)

Chemokine biology : basic research and clinical application /
per: Moser, Bernhard, 1956-, et al.
Publicat: (2006)

Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
per: Nicolas Jacquelot, et al.
Publicat: (2018-10-01)

Metástasis raquídea de hepatocarcinoma
per: Pedro Benedek, et al.
Publicat: (1979-03-01)

PROTEN TYROSINE PHOSPHATASE ACTIVITY IN RAT ASCITES HEPATOMA CELLS
per: M.Saadat, et al.
Publicat: (1998-12-01)

Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System
per: Amanda E. I. Proudfoot, et al.
Publicat: (2017-08-01)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
per: Dhaiban S, et al.
Publicat: (2020-09-01)

SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study
per: Yanchen Lv, et al.
Publicat: (2024-05-01)

The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis
per: Chung-Shu Lee, et al.
Publicat: (2025-05-01)

Anticarcinogenic Efficacy of Fucoxanthin on HepG2 Cell Lines
per: P Sangavi, et al.
Publicat: (2022-02-01)

Chemokines in tumor proximal fluids
per: Jaromír Kotyza
Publicat: (2017-03-01)

CC chemokines and receptors in osteoarthritis: new insights and potential targets
per: Yuchen Zhang, et al.
Publicat: (2023-07-01)

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
per: Takumi Kawaguchi, et al.
Publicat: (2022-04-01)

SGLT2 Inhibitors as Potential Anticancer Agents
per: Debasish Basak, et al.
Publicat: (2023-06-01)

Chemokine Biology [electronic resource]: Basic Research and Clinical Application/
per: Neote, Kuldeep, et al.
Publicat: (2007)

Chemokine Biology [electronic resource]: Basic Research and Clinical Application/
per: Neote, Kuldeep, et al.
Publicat: (2007)

Cytokines, Chemokines, and Chemokine Receptors Quantitative Expressions in Patients with Ovarian Cancer
per: Somayeh Rezaeifard, et al.
Publicat: (2015-05-01)

Chemokines in Innate and Adaptive Granuloma Formation
per: Stephen Wesley Chensue
Publicat: (2013-02-01)

Advances in chemokines of teleost fish species
per: Hongsen Xu, et al.
Publicat: (2024-03-01)

Perspective: Insights on the Nomenclature of Cytokines and Chemokines
per: Albert Zlotnik
Publicat: (2020-05-01)

GENE POLYMORPHISM ANALYSIS OF CHEMOKINES, CHEMOKINE RECEPTORS, ACUTE PHASE PROTEINS, AND CD14 IN FEMALE OBESITY DEVELOPMENT
per: O. V. Kochetova, et al.
Publicat: (2018-11-01)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
per: Kausar Humera, et al.
Publicat: (2011-11-01)

Inflammatory Chemokines in Atherosclerosis
per: Selin Gencer, et al.
Publicat: (2021-01-01)